Authors


Amy Robinson, PhD

Latest:

Meningitis Vaccine Manufacturing: Fermentation Harvest Procedures Affect Purification

Careful analysis of an unusual precipitate identifies defects.




Priyabrata Pattnaik, PhD

Latest:

Tangential Flow Filtration for the Recovery of Acellular Pertussis Vaccine Components

Membrane-based TFF technology can ease scale-up and provide a higher recovery percentage compared to conventional purification methods.


Donald L. Miller

Latest:

Mathematical Programming for the Design and Analysis of a Biologics Facility-Part 2

An algorithmic approach to fine tune facility design and predict capacity.




Mark Schenerman

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Marc Puich

Latest:

How to Make Improvement Programs Work

A true visionary leadership is required to drive the progress of operational excellence programs in biopharmaceutical organizations



Chester A. Meyers, PhD

Latest:

Quality by Design and Compliance Readiness

How will implementing Quality by Design strategies affect your compliance status?




Samantha Sheridan

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Eluemuno R. Blyden, PhD

Latest:

New Approaches to Improved Vaccine Manufacturing in Embryonated Eggs

Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.


Taruna Arora

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Deepalakshmi P. Dakshinamoorthy

Latest:

Rapid Assessment of Molecular Similarity between a Candidate Biosimilar and an Innovator Monoclonal Antibody Using Complementary LC–MS Methods

Intact protein LC–MS detected a mass variance of 62 Da and peptide mapping located a difference of two amino acids.



S.V. Kapre, PhD

Latest:

Tangential Flow Filtration for the Recovery of Acellular Pertussis Vaccine Components

Membrane-based TFF technology can ease scale-up and provide a higher recovery percentage compared to conventional purification methods.


Samir U. Sane

Latest:

Biopharmaceutical Manufacturing Using Blow–Fill–Seal Technology

The authors give special consideration factors affecting blow–fill–seal technology.



John R. Rydall

Latest:

Modular Construction: Innovation, Flexibility, and Adaptibility by Design

Identifying issues in the factory that traditionally arise in the field minimized onsite equipment rework and subsequent qualification work.


Ryan C. Anderson

Latest:

Characterization of Aluminum Hydroxide Gel and Oil-in-Water Emulsion Formulations Containing CpG ODNs

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).



Asish Chakraborty, PhD

Latest:

Rapid Assessment of Molecular Similarity between a Candidate Biosimilar and an Innovator Monoclonal Antibody Using Complementary LC–MS Methods

Intact protein LC–MS detected a mass variance of 62 Da and peptide mapping located a difference of two amino acids.


Amit Banerjee

Latest:

Fermentation Process Technology Transfer for Production of a Recombinant Vaccine Component

The authors describe challenges faced in transfer and scale-up of a fermentation process.


Stefanie Pluschkell

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Meg Casais

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Lisa Crossley, PhD

Latest:

Protein Characterization Through the Stages

Biomanufacturers should follow a risk-based approach to decide which methods to use to characterize their products.


Thomas S. Vedvick

Latest:

Characterization of Aluminum Hydroxide Gel and Oil-in-Water Emulsion Formulations Containing CpG ODNs

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).

© 2024 MJH Life Sciences

All rights reserved.